Coordinatore | INTERUNIVERSITAIR MICRO-ELECTRONICA CENTRUM VZW
Organization address
address: Kapeldreef 75 contact info |
Nazionalità Coordinatore | Belgium [BE] |
Totale costo | 5˙243˙621 € |
EC contributo | 3˙780˙000 € |
Programma | FP7-NMP
Specific Programme "Cooperation": Nanosciences, Nanotechnologies, Materials and new Production Technologies |
Code Call | FP7-NMP-2011-SMALL-5 |
Funding Scheme | CP-FP |
Anno di inizio | 2012 |
Periodo (anno-mese-giorno) | 2012-03-01 - 2015-02-28 |
# | ||||
---|---|---|---|---|
1 |
INTERUNIVERSITAIR MICRO-ELECTRONICA CENTRUM VZW
Organization address
address: Kapeldreef 75 contact info |
BE (LEUVEN) | coordinator | 523˙841.00 |
2 |
THE HEBREW UNIVERSITY OF JERUSALEM.
Organization address
address: GIVAT RAM CAMPUS contact info |
IL (JERUSALEM) | participant | 530˙345.00 |
3 |
UNIVERSITEIT ANTWERPEN
Organization address
address: PRINSSTRAAT 13 contact info |
BE (ANTWERPEN) | participant | 454˙240.00 |
4 |
MULTI CHANNEL SYSTEMS MCS GMBH
Organization address
address: ASPENHAUSTRASSE 21 contact info |
DE (REUTLINGEN) | participant | 440˙920.00 |
5 |
UNIVERSITAT AUTONOMA DE BARCELONA
Organization address
address: Campus UAB -BELLATERRA- s/n contact info |
ES (CERDANYOLA DEL VALLES) | participant | 383˙874.00 |
6 |
SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO SANT'ANNA
Organization address
address: PIAZZA MARTIRI DELLA LIBERTA, 33 contact info |
IT (PISA) | participant | 381˙441.00 |
7 |
NEURODAN AS
Organization address
address: SOFIENDALSVEJ 85 contact info |
DK (AALBORG) | participant | 357˙636.00 |
8 |
AALBORG UNIVERSITET
Organization address
address: FREDRIK BAJERS VEJ 5 contact info |
DK (AALBORG) | participant | 317˙034.00 |
9 |
UNIVERSITAETSMEDIZIN GOETTINGEN - GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS
Organization address
address: Robert-Koch-Strasse 40 contact info |
DE (GOETTINGEN) | participant | 248˙140.00 |
10 |
NANO6 SRO
Organization address
address: NAMESTI SITNA 3105 contact info |
CZ (KLADNO) | participant | 142˙529.00 |
11 |
OTTO BOCK HEALTHCARE GMBH
Organization address
address: MAX-NAEDER-STRASSE 15 contact info |
DE (DUDERSTADT) | participant | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'The main goal of this proposal is to bring novel technology of biocompatible, low bio-fouling, high electrochemical performance carbon nanomaterials to in-vivo preclinical applications and at the same time to use this materials to develop a highly advanced concept of intimate intracellular contact, based on bottom - up technology of, engulfing the micro-electrode by neural cells. Such bionic interfaces resemble true intrinsic physiological properties of neural somas and form a tight, extremely low-invasive bidirectional coupling for both motor and sensory functions. Advantage of our approach is unperfected fidelity of signals and resolution of single neuron fibers to be coupled to one protruding electrode. The research targets are devices ranging from cuff or lead electrodes to novel bidirectional interfaces for both sensory and motor functions for cybernetic mind-controlled prosthetics. Instead of re-targeting to an entire muscle, our research comes thus with a technique how to couple neurons by an intracellular way to form a single microelectrode-axon stimulating device and at the same time to provide sensory input , being on the front edge of research on bionic interfaces for novel neuroprosthetics. The proposed technology takes advantage of unique properties of well established nanodiamond thin films, with their unique and the simple carbon chemistry allowing integration with antibactericidal and anti-inflammatory surfaces. MERIDIAN will demonstrate devices in in-vivo studies and in preclinical tests on humans and benchmark fabricated devices with the current state of the art bionic system on the market.'
EU-funded scientists are developing novel electrode technology to simulate communication between single neurons and muscle fibres. The prosthetics should pioneer breakthrough treatments for conditions from urinary incontinence to neurodegenerative disease.